Skip to content

News

OCRA Awards $6.6 Million in Ovarian Cancer Research Grants for 2020

OCRA Awards $6.6 Million in Ovarian Cancer Research Grants for 2020

(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape. In 2020, along with our other ongoing grants and programs, OCRA is investing nearly $9 million in the fight against ovarian cancer. These grants, awarded internationally for … Continued

OCRA-Funded Research Advances Immunotherapy

OCRA-Funded Research Advances Immunotherapy

(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr. Gitto and her colleagues at the University of Pennsylvania successfully created patient “avatars,” which mimic a patient’s biological profile based on a number of factors. Using these … Continued

Ovarian Cancer Community Applauds Congress for Providing $35 Million in Ovarian Cancer Research Funding at the Department of Defense in FY 2020 Spending Bill

Ovarian Cancer Community Applauds Congress for Providing $35 Million in Ovarian Cancer Research Funding at the Department of Defense in FY 2020 Spending Bill

WASHINGTON, D.C. – December 20, 2019 – Later today, President Trump is expected to sign into law a spending package that funds the government for the remainder of Fiscal Year (FY) 2020 and includes a significant increase in funding for the Ovarian Cancer Research Program (OCRP) at the Department of Defense (DoD). The legislation funds … Continued

Woman to Woman Meets Patients When and Where They Need It Most

Woman to Woman Meets Patients When and Where They Need It Most

(December 19, 2019) A cancer diagnosis can bring with it a bevy of complicated responses, including fear, anger, and even guilt. No one should have to navigate these tricky waters alone. Every day, OCRA’s Woman to Woman peer support programs across the country help hundreds of women diagnosed with gynecologic cancer receive the emotional support … Continued

OCRA-Funded Research Breakthroughs in 2019

OCRA-Funded Research Breakthroughs in 2019

OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives. Our grantees have made incredible progress toward better understanding and eradicating ovarian cancer. Their findings will have real-life impact for women and families battling this disease — and these stunning advancements would … Continued

OCRA Research Reveals Two Cells of Origin for High Grade Ovarian Cancer

OCRA Research Reveals Two Cells of Origin for High Grade Ovarian Cancer

(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community. Prior research has suggested the cancer arises from the fallopian tube epithelium, and other evidence supports the theory that ovarian surface epithelium cells are the site of origin.  OCRA-funded research by Shuang Zhang, PhD, from … Continued

A Holiday Message From Audra Moran

A Holiday Message From Audra Moran

Friends, The day before Thanksgiving is a busy one for me, and I imagine, for you too. But before I turn my attention to holiday prep, I wanted to sit down and write this email to you, and everyone who supports OCRA. THANK YOU. It’s hard to overstate the deep gratitude I feel when I … Continued

#GivingTuesday is December 3rd — Join Us in #GivingTeal

#GivingTuesday is December 3rd — Join Us in #GivingTeal

(November 25, 2019) This Giving Tuesday, we need your help to make a big impact. For the 22,000 American women diagnosed with ovarian cancer every year, and the 200,000 living with this disease, we’re asking you to join us in #GivingTeal. Here’s how you can help. Be an OCRA Holiday Hero Spread the word and … Continued

OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers

OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers

(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide. Specifically, ARID1A controls expression of another protein called STAG1 that is required to keep chromosome ends together. When ARID1A … Continued

OCRA’s STYLE LAB Shines a Spotlight on Ovarian Cancer

OCRA’s STYLE LAB Shines a Spotlight on Ovarian Cancer

That’s a wrap on #OCRAStyleLab, and what an evening it was for ovarian cancer awareness! (November 6, 2019) Our sincere gratitude to our amazing hosts Maggie Gyllenhaal and Kate Mara, the fabulous En Vogue, media partner InStyle and all the incredible supporters who joined us for this meaningful night to shine a spotlight on ovarian … Continued

OCRA-Funded Research Explores New Pathways for Understanding Metastases

OCRA-Funded Research Explores New Pathways for Understanding Metastases

In an effort to further understand disease initiation and progression, OCRA grantee Dr. Sumegha Mitra, along with colleagues at Indiana University, conducted research which revealed key changes in gene expression occurring during the initiation and early metastasis of ovarian cancer. Dr. Mitra and colleagues identified targets and pathways which can be explored in the future … Continued

Newk’s Eatery & Newk’s Cares Hit $1.4 Million Raised For Ovarian Cancer Research

Newk’s Eatery & Newk’s Cares Hit $1.4 Million Raised For Ovarian Cancer Research

(October 28, 2019) Newk’s Cares, the ovarian cancer awareness movement and national campaign founded by fast-casual restaurant Newk’s Eatery, has reached monumental heights! Celebrating its sixth year, Newk’s Cares raised more than $400,000 in September—their largest total to date to support OCRA—and has now surpassed $1.4M raised for ovarian cancer research! Newk’s Cares honors the … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.